## Abstract A substantial percentage of patients with newly diagnosed Parkinson's disease without dementia are reported to be affected by cognitive impairment (CI). In practice, however, CI is underrecognized, as the signs may not be apparent in earlyβstage disease and many routine assessment tools
The economic impact of cognitive impairment in Parkinson's disease
β Scribed by Corinna Vossius; Jan P. Larsen; Carmen Janvin; Dag Aarsland
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 565 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background:
We investigated to what extent cognitive impairment and dementia were related to the direct medical and nonmedical costs in Parkinson's disease.
Methods:
Sixtyβone patients with Parkinson's disease from a populationβbased cohort were assessed for motor and cognitive symptoms in 1993, 1997, and 2001. Data on use of health care and social services were collected.
Results:
The costs of patients with dementia were 3.3 times higher (β¬34,980) than those of nondemented patients (β¬10,626) per year of survival. Institutional care was the largest cost factor, representing 67% of the costs. Cognitive functioning predicted direct costs by 29.4%. Cognitive decline was associated with increased costs, even in nondemented subjects.
Conclusions:
Our findings suggest that dementia has a substantial impact on direct costs in Parkinson's disease, mainly due to high costs for institutional care. In addition, there were indications that even patients with mild cognitive impairment have higher nonmedical costs. Β© 2011 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract There is growing interest in identifying Parkinson's disease (PD) patients with mild cognitive impairment (PDβMCI), but widely disparate criteria have been used. We assessed 143 PD patients and 50 matched controls on 20 measures across 4 cognitive domains (executive function, attention
## Abstract Our purpose was to characterize a state of mild cognitive impairment (MCI) in Parkinson's disease (PD) (PDβMCI) that would be analogous to the MCI that is posited as a precursor of Alzheimer's disease (AD). We categorized 86 PD subjects in a brain bank population as either cognitively n
## Abstract Patients with Parkinson's disease (PD) may present impairment in cognitive functions even at early stages of the disease. When compared with the general population, their risk of dementia is five to six times higher. Recent investigations using structural MRI have shown that dementia in
## Abstract Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based o
## Abstract Some degree of cognitive impairment appears frequently in Parkinson's disease (PD) patients, even at the onset of the disease. However, due to the heterogeneity of the patients and the lack of standardized assessment batteries, it remains unclear which capacities are primarily affected